UK Trials Weight Loss Drugs to Combat Unemployment Crisis

The United Kingdom will investigate if weight loss drugs can help reduce unemployment. Health Minister Wes Streeting announced a five-year trial in Greater Manchester involving Eli Lilly’s weight loss drugs, Mounjaro and Zepbound.

Weight Loss Drug Experiment in the UK

During a recent summit, Prime Minister Keir Starmer welcomed Eli Lilly, which announced a £279 million investment in the UK. About 3,000 residents will participate in the trial to evaluate the long-term impacts of these drugs. Currently, 25.9% of UK adults are obese and 37.9% are overweight.

UK Unemployment Rate

As of August 2024, the unemployment rate in the UK is 4%. The number of employed people aged 16-64 stands at 75%. However, 9.26 million individuals, aged 16-64, are economically inactive, meaning they are not in jobs and not seeking work.

Connection Between Weight Loss Drugs and Unemployment

Obesity can impact employment, but it is not the sole reason for joblessness. Some experts note that while unemployed individuals often face issues with obesity, there is no direct link proving that obesity causes unemployment. The hope is that this trial may show if weight loss drugs can lead to higher workplace productivity.

How Weight Loss Drugs Work

Weight loss drugs suppress appetite. The main medications include Novo Nordisk’s Wegovy and Ozempic, along with Eli Lilly’s Mounjaro and Zepbound. These drugs mimic a hormone called glucagon-like peptide-1 (GLP-1), which indicates satiety to the brain. Tirzepatide, used in Mounjaro and Zepbound, works with a second hormone known as gastric inhibitory polypeptide (GIP).

Potential Weight Loss with These Drugs

People using tirzepatides generally experience greater weight loss than with semiglutides. While Mounjaro and Ozempic are approved for diabetes, Wegovy and Zepbound are approved for weight loss.

Is Weight Loss Permanent?

Clinical trials indicate that stopping these drugs often leads to regaining lost weight within a year.

Side Effects of Weight Loss Drugs

Common side effects of Mounjaro include nausea, diarrhea, and stomach pain. Serious risks involve potential thyroid tumors and pancreatitis. Users must stay hydrated and be cautious of severe allergic reactions and changes in vision.